Survey on the SUPPORT Act's Prescription Drug Monitoring Program Mandate
MO HealthNet is conducting a survey regarding the implementation of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act's prescription drug monitoring program mandate.
The SUPPORT Act, signed into law on October 24, 2018, required that states mandate that covered providers consult a qualified prescription drug monitoring program (PDMP) before prescribing controlled substances to covered individuals. Moreover, beginning with the Federal Fiscal Year (FFY) 2023, states must report annual data about the use of PDMPs by covered providers before prescribing controlled substances to the Department of Health and Human Services (HHS).
To help assess the implementation of this mandate, we would appreciate your participation in this survey. The survey should take 5 minutes, and your responses will be confidential.
You can take the survey online.
MO HealthNet appreciates your participation.